Citations (39)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Lauren Brown, Ting-hsuan Lee, Manuela De Allegri, Krishna Rao & John FP. Bridges. (2017) Applying stated-preference methods to improve health systems in sub-Saharan Africa: a systematic review. Expert Review of Pharmacoeconomics & Outcomes Research 17:5, pages 441-458.
Read now
Read now
Articles from other publishers (38)
Catherine Lejeune, Abderrahmane Bourredjem, Christine Binquet, Olivier Cussenot, Guillaume Boudrant, Frédéric Papillon, Franck Bruyère, Olivier Haillot, Nicolas Koutlidis, Sébastien Bassard, Georges Fournier, Antoine Valeri, Jean-Luc Moreau, Bruno Pierfitte, Morgan Moulin, Célia Berchi & Luc Cormier. (2023) Eliciting men’s preferences for decision-making relative to treatments of localized prostate cancer with a good or moderate prognosis. World Journal of Urology.
Crossref
Crossref
Daniel D. Joyce, Jon C. Tilburt, Joel E. Pacyna, Kristin Cina, Daniel G. Petereit, Kathryn R. Koller, Christie A. Flanagan, Barbara Stillwater, Mariam Miller, Judith S. Kaur, Elizabeth Peil, David Zahrieh, Amylou C. Dueck, Victor M. Montori, Dominick L. Frosch, Robert J. Volk & Simon P. Kim. (2023) The Impact of Within-Consultation and Preconsultation Decision Aids for Localized Prostate Cancer on Patient Knowledge: Results of a Patient-Level Randomized Trial. Urology 175, pages 90-95.
Crossref
Crossref
Amy Brown, Jackie Yim, Scott Jones, Alex Tan, Emily Callander, Kerrianne Watt, Richard De Abreu Lourenco & Tilley Pain. (2023) Men’s perceptions and preferences regarding prostate cancer radiation therapy: A systematic scoping review. Clinical and Translational Radiation Oncology 38, pages 28-42.
Crossref
Crossref
Shan Jiang, Ru Ren, Yuanyuan Gu, Varinder Jeet, Ping Liu & Shunping Li. (2022) Patient Preferences in Targeted Pharmacotherapy for Cancers: A Systematic Review of Discrete Choice Experiments. PharmacoEconomics 41:1, pages 43-57.
Crossref
Crossref
Margaret Husted, Debra Gray, Sarah E. Golding & Richard Hindley. (2022) Reaching a Tipping Point: A Qualitative Exploration of Quality of Life and Treatment Decision-Making in People Living With Benign Prostatic Hyperplasia. Qualitative Health Research 32:13, pages 1979-1992.
Crossref
Crossref
Yuta Yamada, Satoru Taguchi & Haruki Kume. (2022) Surgical Tolerability and Frailty in Elderly Patients Undergoing Robot-Assisted Radical Prostatectomy: A Narrative Review. Cancers 14:20, pages 5061.
Crossref
Crossref
Ilene L. Hollin, Jonathan Paskett, Anne L. R. Schuster, Norah L. Crossnohere & John F. P. Bridges. (2022) Best–Worst Scaling and the Prioritization of Objects in Health: A Systematic Review. PharmacoEconomics 40:9, pages 883-899.
Crossref
Crossref
Amy Brown, Tilley Pain, Alex Tan, Lux Anable, Emily Callander, Kerrianne Watt, Deborah Street & Richard De Abreu Lourenco. (2022) Men’s preferences for image-guidance in prostate radiation therapy: A discrete choice experiment. Radiotherapy and Oncology 167, pages 49-56.
Crossref
Crossref
Martin J. Connor, Mesfin G. Genie, David Burns, Edward J. Bass, Michael Gonzalez, Naveed Sarwar, Alison Falconer, Stephen Mangar, Tim Dudderidge, Vincent Khoo, Mathias Winkler, Hashim U. Ahmed & Verity Watson. (2022) A Systematic Review of Patients’ Values, Preferences, and Expectations for the Treatment of Metastatic Prostate Cancer. European Urology Open Science 36, pages 9-18.
Crossref
Crossref
Shellie D. Ellis, Soohyun Hwang, Emily Morrow, Kim S. Kimminau, Kelly Goonan, Laurie Petty, Edward Ellerbeck & J. Brantley Thrasher. (2021) Perceived barriers to the adoption of active surveillance in low-risk prostate cancer: a qualitative analysis of community and academic urologists. BMC Cancer 21:1.
Crossref
Crossref
Christopher J.D. Wallis, Daniel D. Joyce, Zachary Klaassen, Amy N. Luckenbaugh, Aaron A. Laviana, David Penson, Stacie B. Dusetzina & Daniel A. Barocas. (2021) Out-of-pocket costs for commercially insured patients with localized prostate cancer. Urologic Oncology: Seminars and Original Investigations 39:12, pages 797-805.
Crossref
Crossref
Nancy P. Mendenhall, Sarah M. Rausch Osian, Curtis M. Bryant, Bradford S. Hoppe & Christopher G. Morris. (2021) What men want: Results from a national survey on decision making for prostate cancer treatment and research participation. Clinical and Translational Science 14:6, pages 2314-2326.
Crossref
Crossref
Anne M. Rentz, Sonal G. Mansukhani, Jinan Liu, Andrew J. Lloyd, Sebastian Heidenreich, Louis S. Matza, Nancy A. Dawson, Neal Shore & Stephen J. Freedland. (2021) Patients’ preferences for delaying metastatic castration-resistant prostate cancer: Combining health state and treatment valuation. Urologic Oncology: Seminars and Original Investigations 39:6, pages 367.e7-367.e17.
Crossref
Crossref
M.J. Costin & L.E. Makaroff. (2021) Bladder Preservation With Radiotherapy: The Patient Perspective. Clinical Oncology 33:6, pages 346-349.
Crossref
Crossref
S. Wilson Beckham, Norah L. Crossnohere, Margaret Gross & John F. P. Bridges. (2020) Eliciting Preferences for HIV Prevention Technologies: A Systematic Review. The Patient - Patient-Centered Outcomes Research 14:2, pages 151-174.
Crossref
Crossref
Melina J. Windon, Daisy Le, Gypsyamber D'Souza, Elaine Bigelow, Karen Pitman, Emily Boss, David W. Eisele & Carole Fakhry. (2021) Treatment decision-making among patients with oropharyngeal squamous cell cancer: A qualitative study. Oral Oncology 112, pages 105044.
Crossref
Crossref
Hannah Riskin-Jones, Tristan Grogan, Amar Kishan & Ann Raldow. (2020) Impact of Health-related Quality of Life and Prediagnosis Risk of Major Depressive Disorder on Treatment Choice in Low- and Intermediate-Risk Prostate Cancer. European Urology Open Science 21, pages 69-76.
Crossref
Crossref
Christian J. Konopka, Marcin Woźniak, Jamila Hedhli, Anna Siekierzycka, Jarosław Skokowski, Rafał Pęksa, Marcin Matuszewski, Gnanasekar Munirathinam, Andre Kajdacsy-Balla, Iwona T. Dobrucki, Leszek Kalinowski & Lawrence W. Dobrucki. (2020) Quantitative imaging of the receptor for advanced glycation end-products in prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging 47:11, pages 2562-2576.
Crossref
Crossref
Mark V. Mishra, Winter Maxwell Thayer, Ellen Janssen, Bradford Hoppe, Caitlin Eggleston & John F. P. Bridges. (2020) Patient preferences for reducing bowel adverse events following prostate radiotherapy. PLOS ONE 15:7, pages e0235616.
Crossref
Crossref
Brandon S. Imber, Melissa Varghese, Behfar Ehdaie & Daniel Gorovets. (2019) Financial toxicity associated with treatment of localized prostate cancer. Nature Reviews Urology 17:1, pages 28-40.
Crossref
Crossref
Cihan Gani, Nina Gani, Sebastian Zschaeck, Fabian Eberle, Norbert Schaeffeler, Thomas Hehr, Bernhard Berger, Stefan Georg Fischer, Johannes Claßen, Stephan Zipfel, Claus Rödel, Martin Teufel & Daniel Zips. (2019) Organ Preservation in Rectal Cancer: The Patients' Perspective. Frontiers in Oncology 9.
Crossref
Crossref
Jae Heon Kim, So Young Kim, Seok-Joong Yun, Jae Il Chung, Hoon Choi, Ho Song Yu, Yun-Sok Ha, In-Chang Cho, Hyung Joon Kim, Hyun Chul Chung, Jun Sung Koh, Wun-Jae Kim, Jong-Hyock Park & Ji Youl Lee. (2019) Medical Travel among Non-Seoul Residents to Seek Prostate Cancer Treatment in Medical Facilities of Seoul. Cancer Research and Treatment 51:1, pages 53-64.
Crossref
Crossref
Rahul Khairnar, Mark V. Mishra & Eberechukwu Onukwugha. (2018) Impact of United States Preventive Services Task Force Recommendations on Utilization of Prostate-specific Antigen Screening in Medicare Beneficiaries. American Journal of Clinical Oncology 41:11, pages 1069-1075.
Crossref
Crossref
Melina J Windon, Gypsyamber D'Souza & Carole Fakhry. (2018) Treatment preferences in human papillomavirus-associated oropharyngeal cancer. Future Oncology 14:24, pages 2521-2530.
Crossref
Crossref
Katya Tentori, Stefania Pighin, Claudio Divan & Vincenzo Crupi. (2018) Mind the gap: Physicians’ assessment of patients’ importance weights in localized prostate cancer. PLOS ONE 13:7, pages e0200780.
Crossref
Crossref
Archana Radhakrishnan, David Grande, Nandita Mitra & Craig Evan Pollack. (2018) Which Patients Report That Their Urologists Advised Them to Forgo Initial Treatment for Prostate Cancer?. Urology 115, pages 133-138.
Crossref
Crossref
Katarina Luise Matthes, Manuela Limam, Giulia Pestoni, Leonhard Held, Dimitri Korol & Sabine Rohrmann. (2018) Impact of comorbidities at diagnosis on prostate cancer treatment and survival. Journal of Cancer Research and Clinical Oncology 144:4, pages 707-715.
Crossref
Crossref
Mo Zhou, Winter Maxwell Thayer & John F. P. Bridges. (2017) Using Latent Class Analysis to Model Preference Heterogeneity in Health: A Systematic Review. PharmacoEconomics 36:2, pages 175-187.
Crossref
Crossref
Donna L. Berry, Fangxin Hong, Traci M. Blonquist, Barbara Halpenny, Christopher P. Filson, Viraj A. Master, Martin G. Sanda, Peter Chang, Gary W. Chien, Randy A. Jones, Tracey L. Krupski, Seth Wolpin, Leslie Wilson, Julia H. Hayes, Quoc-Dien Trinh, Mitchell Sokoloff & Prabhakara Somayaji. (2018) Decision Support with the Personal Patient Profile-Prostate: A Multicenter Randomized Trial. Journal of Urology 199:1, pages 89-97.
Crossref
Crossref
Lara Bellardita, Paola Dordoni, Letizia De Luca, Julia Paola Menichetti Delor & Riccardo Valdagni. 2018. Active Surveillance for Localized Prostate Cancer. Active Surveillance for Localized Prostate Cancer
149
167
.
James Abe, Jennifer M. Lobo, Daniel M. Trifiletti & Timothy N. Showalter. (2017) Providing guidance for genomics-based cancer treatment decisions: insights from stakeholder engagement for post-prostatectomy radiation therapy. BMC Medical Informatics and Decision Making 17:1.
Crossref
Crossref
Tsung Yu, Nomin Enkh-Amgalan & Ganchimeg Zorigt. (2017) Methods to perform systematic reviews of patient preferences: a literature survey. BMC Medical Research Methodology 17:1.
Crossref
Crossref
Eric Raffin, Tracy Onega, Julie Bynum, Andrea Austin, Donald Carmichael, Kristen Bronner, Philip Goodney & Elias S. Hyams. (2017) Are there regional tendencies toward controversial screening practices? A study of prostate and breast cancer screening in a Medicare population. Cancer Epidemiology 50, pages 68-75.
Crossref
Crossref
Lina Eliasson, Hayley M. de Freitas, Lindsay Dearden, Brian Calimlim & Andrew J. Lloyd. (2017) Patients’ Preferences for the Treatment of Metastatic Castrate-resistant Prostate Cancer: A Discrete Choice Experiment. Clinical Therapeutics 39:4, pages 723-737.
Crossref
Crossref
Romy E.D. Lamers, Maarten Cuypers, Marieke de Vries, Lonneke V. van de Poll-Franse, J.L.H. Ruud Bosch & Paul J.M. Kil. (2017) How do patients choose between active surveillance, radical prostatectomy, and radiotherapy? The effect of a preference-sensitive decision aid on treatment decision making for localized prostate cancer. Urologic Oncology: Seminars and Original Investigations 35:2, pages 37.e9-37.e17.
Crossref
Crossref
Sarah T. Hawley & Arden M. Morris. (2017) Cultural challenges to engaging patients in shared decision making. Patient Education and Counseling 100:1, pages 18-24.
Crossref
Crossref
Bruce L. Jacobs, Samia H. Lopa, Jonathan G. Yabes, Joel B. Nelson, Amber E. Barnato & Howard B. Degenholtz. (2016) Association of functional status and treatment choice among older men with prostate cancer in the Medicare Advantage population. Cancer 122:20, pages 3199-3206.
Crossref
Crossref
Vinayak Muralidhar, Brent S. Rose, Yu-Wei Chen, Michelle D. Nezolosky & Paul L. Nguyen. (2016) Association Between Travel Distance and Choice of Treatment for Prostate Cancer: Does Geography Reduce Patient Choice?. International Journal of Radiation Oncology*Biology*Physics 96:2, pages 313-317.
Crossref
Crossref